Synthesis, Cruzain Docking, and in vitro Studies of Aryl‐4‐Oxothiazolylhydrazones Against Trypanosoma cruzi
Authors:
- Ana Cristina Lima LeiteALAna Cristina Lima Leite
- Diogo Rodrigo de M. MoreiraDMDiogo Rodrigo de M. Moreira
- Marcos V. de O. CardosoMCMarcos V. de O. Cardoso
- Marcelo Zaldini HernandesMHMarcelo Zaldini Hernandes
- Ricardo O. SilvaRSRicardo O. Silva
- Alice C. KiperstokAKAlice C. Kiperstok
- Milena B. P. SoaresMSMilena B. P. Soares
- 31 August 2007
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 2 (9) , 1339-1345
Abstract
Research in recent years has demonstrated that the Trypanosoma cruzi cysteine protease cruzain (TCC) is a valid chemotherapeutic target. Herein we describe a small library of aryl‐4‐oxothiazolylhydrazones that have been tested in assays against T. cruzi cell cultures. The docking studies carried out suggest that these compounds are potential ligands for the TCC enzyme. The most promising compound of this series, N‐(4‐oxo‐5‐ethyl‐2′‐thiazolin‐2‐yl)‐N′‐phenylthio‐(Z)‐ethylidenehydrazone (6 f), was shown to be very active at non‐cytotoxic concentrations in in vitro assays with mammalian cells and has a potency comparable with reference drugs such as nifurtimox (Nfx) and benznidazole (Bdz).Keywords
This publication has 28 references indexed in Scilit:
- Cysteine Proteinase Inhibitors as Therapy for Parasitic Diseases: Advances in Inhibitor DesignMini-Reviews in Medicinal Chemistry, 2006
- Trypanocidal agents with low cytotoxicity to mammalian cell line: A comparison of the theoretical and biological features of lapachone derivativesBioorganic & Medicinal Chemistry, 2006
- In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazonesBioorganic & Medicinal Chemistry, 2004
- The Synthesis of Parasitic Cysteine Protease and Trypanothione Reductase InhibitorsCurrent Medicinal Chemistry, 2003
- Mechanism of Action of 4-Phenoxyphenoxyethyl Thiocyanate (WC-9) against Trypanosoma cruzi , the Causative Agent of Chagas’ DiseaseAntimicrobial Agents and Chemotherapy, 2003
- 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruziJournal of Computer-Aided Molecular Design, 2003
- Protein structure-based design of anti-protozoal drugsJournal of the Brazilian Chemical Society, 2002
- Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma bruceiInternational Journal of Antimicrobial Agents, 2002
- Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of actionInternational Journal for Parasitology, 1999
- Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitorsBioorganic & Medicinal Chemistry, 1998